⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Rakesh MehtaMD

Hematology-Oncology · Indianapolis, IN 46202

NPI: 1174589600

Share:𝕏fin

33

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers90th percentile opioid prescribingElevated cost per beneficiary

Risk indicators are statistical patterns, not allegations. Learn more

1,860

Total Claims

$1.1M

Drug Cost

165

Beneficiaries

$6,371

Cost/Patient

Risk Score Breakdown 33/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Opioid rate (national percentile)+5
Cost per patient outlier+3

Score components are additive. Read full methodology

Peer Comparison vs. 8,541 Hematology-Oncology providers

+598%

Opioid rate vs peers

43.8% vs 6.3% avg

-53%

Cost per patient vs peers

$6,371 vs $14K avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

Opioid Prescribing

43.8%

Opioid Rate

814

Opioid Claims

$95K

Opioid Cost

28.7%

Long-Acting Rate

This provider's opioid prescribing rate of 43.8% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

100% generic

Brand: 0 claims · $0

Generic: 1,392 claims · $147K

Patient Profile

60

Avg Age

59%

Female

2.59

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About